These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 6451692)

  • 21. Penicillamine in the treatment of rheumatoid arthritis.
    Camp AV
    J Rheumatol Suppl; 1981; 7():103-6. PubMed ID: 6939871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and toxicity of D-penicillamine for rheumatoid disease in the elderly.
    Kean WF; Anastassiades TP; Dwosh IL; Ford PM; Kelly WG; Dok CM
    J Am Geriatr Soc; 1982 Feb; 30(2):94-100. PubMed ID: 6460054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The place of levamisole in the armamentarium for rheumatoid arthritis.
    Huskisson EC
    J Rheumatol Suppl; 1978; 4():149-52. PubMed ID: 282445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chlorbutin, azathioprine, D-penicillamine and levamisole (decaris) in the treatment of patients with rheumatoid arthritis. IV. Comparative evaluation of their effects on systemic (extra-articular) manifestations of the disease].
    Krel' AA; Kanevskaia MZ; Chichasova NV; Khamishon LZ; Nemchenov EN
    Ter Arkh; 1985; 57(8):44-52. PubMed ID: 3906995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Side effects of d-penicillamine in the treatment of rheumatoid arthritis].
    Mazzanti G; Paladini G; Damiani D; Bianchini D; Florean M; Mesesnel E; Cataldo R
    Minerva Med; 1986 May; 77(22-23):1009-16. PubMed ID: 2941698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Penicillamine and other remittive agents in rheumatoid arthritis: comparisons and interaction.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    Clin Invest Med; 1984; 7(1):59-63. PubMed ID: 6723126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of the hematological side effects of levamisole in rheumatoid arthritis with recommendations.
    Mielants H; Veys EM
    J Rheumatol Suppl; 1978; 4():77-83. PubMed ID: 282448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The basic treatment of rheumatoid arthritis. Current trends].
    Suţeanu S; Manuchian M
    Med Interne; 1984; 22(4):241-51. PubMed ID: 6393302
    [No Abstract]   [Full Text] [Related]  

  • 29. Prior gold therapy does not influence the adverse effects of D-penicillamine in rheumatoid arthritis.
    Kean WF; Lock CJ; Howard-Lock HE; Buchanan WW
    Arthritis Rheum; 1982 Aug; 25(8):917-22. PubMed ID: 6214261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levamisole as basic treatment of rheumatoid arthritis: longterm evaluation.
    Veys EM; Mielants H; Verbruggen G; Dhondt E; Goethals L; Cheroutre L; Buelens H
    J Rheumatol; 1981; 8(1):45-56. PubMed ID: 7218258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cutaneous side effects induced by D-penicillamine in the treatment of rheumatoid arthritis].
    Broggini M; Baratelli E; Cappelli A; Crespi E; Filardi PG; Volontè S
    Minerva Med; 1990 Mar; 81(3):197-201. PubMed ID: 2138721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surveillance costs of gold and penicillamine.
    Somerville W; Caughey DE; Grigor RR
    N Z Med J; 1979 Mar; 89(631):186. PubMed ID: 287942
    [No Abstract]   [Full Text] [Related]  

  • 33. HLA antigens and toxicity to gold and penicillamine in rheumatoid arthritis.
    Scherak O; Smolen JS; Mayr WR; Mayrhofer F; Kolarz G; Thumb NJ
    J Rheumatol; 1984 Oct; 11(5):610-4. PubMed ID: 6439866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential gold and penicillamine therapy in rheumatoid arthritis.
    Halla JT; Cassady J; Hardin JG
    Am J Med; 1982 Mar; 72(3):423-6. PubMed ID: 6174045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimalarial treatment of rheumatoid arthritis: 1985 status.
    Rynes RI
    J Rheumatol; 1985 Aug; 12(4):657-9. PubMed ID: 4057186
    [No Abstract]   [Full Text] [Related]  

  • 36. An assessment of penicillamine therapy in rheumatoid arthritis and the influence of previous gold therapy.
    Webley M; Coomes EN
    J Rheumatol; 1979; 6(1):20-4. PubMed ID: 439106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of levamisole in rheumatoid arthritis: Immune changes and long-term results.
    Feldmann JL; Mery C; Amor B; Kahan A; de Gery A; Delbarre F
    Scand J Rheumatol; 1981; 10(1):1-8. PubMed ID: 7013056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adverse effects of D-penicillamine in rheumatoid arthritis with reference to prior gold therapy].
    Ishihara Y; Fujita A; Ohdoi S; Saitoh K; Katsube S; Azuma T
    Ryumachi; 1985 Feb; 25(1):15-9. PubMed ID: 4002060
    [No Abstract]   [Full Text] [Related]  

  • 39. Gold vs D-penicillamine double blind study and followup.
    Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
    J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The non-hematological side effects of levamisole in the treatment of rheumatoid arthritis--a review.
    Pinals RS
    J Rheumatol Suppl; 1978; 4():71-5. PubMed ID: 282447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.